HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: HIV Resistance and Treatment Strategies
A completed NIAID-sponsored clinical trial update on HIV resistance and potential treatment strategies.
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men [NA]
A completed clinical trial evaluating a specialized cognitive-behavioral counseling program to reduce HIV transmission risk behaviors among …
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV [Phase 1]
Phase 1 clinical trial evaluating a HIV vaccine therapy combined with incomplete Freund's adjuvant and GM-CSF; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test
This document reports on the performance evaluation of Chembio Diagnostic Systems' DPP HIV 1/2 Rapid Test in detecting HIV infections, based…
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Dolutegravir Renal Impairment Study [Phase 1]
A Phase 1 renal impairment study of dolutegravir has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections [Phase 1]
Phase 1 trial evaluating the safety and preliminary effectiveness of a two-drug combination in patients co-infected with hepatitis C and adv…
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects [Phase 2, Phase 3]
Clinical trial evaluating maraviroc with optimized background therapy versus optimized background therapy alone in HIV-1 infection completed…
-
CLINICAL_TRIALS withdrawal · 2012-04-27Clinical Trial Update: A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects [Phase 2]
A Phase 2 multiple ascending dose study of BMS-707035 in HIV-1 infected subjects has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-04-25Clinical Trial Update: A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071) [Phase 3]
Phase 3 comparing once-daily versus twice-daily raltegravir in HIV patients was terminated. Results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-25Clinical Trial Update: A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers [Phase 1]
A Phase 1 HIV vaccine trial evaluating Ad35-GRIN/ENV in healthy adults has completed.
-
FDA approval · 2012-04-20FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir and ritonavir) by AbbVie.
-
FDA approval · 2012-04-20FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved AbbVie’s supplemental application for KALETRA (lopinavir/ritonavir). The approval updates the product labeling related to i…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Safety and Efficacy Study of Switching From Epzicom to Truvada [Phase 4]
Phase 4 safety and efficacy study evaluating switching from Epzicom to Truvada in HIV infection completed; results posted in 2012.
-
FDA approval · 2012-04-18FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approves a supplemental application for Isentress (raltegravir) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2012-04-18FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for ISENTRESS (raltegravir) submitted by Merck Sharp & Dohme LLC. This action confirms FDA approval …
-
CLINICAL_TRIALS trial_result · 2012-04-18Clinical Trial Update: Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects [Phase 4]
Phase 4 trial evaluating boosted Lexiva (fosamprenavir) with Lovaza adjunctive therapy in HIV-infected patients with hypertriglyceridemia. R…
-
CLINICAL_TRIALS trial_result · 2012-04-18Clinical Trial Update: Cardiovascular Prevention for Persons With HIV [NA]
A completed clinical trial update reports results for cardiovascular prevention in persons with HIV, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS [Phase 2]
Phase 2 trial comparing liposomal doxorubicin alone versus in combination with bleomycin and vincristine for Kaposi's sarcoma in AIDS patien…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Aspirin and Antiretroviral Therapy in HIV Infected Patients [Phase 2]
Phase 2 trial evaluating the addition of aspirin to antiretroviral therapy in HIV-infected patients; the study was terminated and results we…
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS [Phase 1, Phase 2]
Completed Phase 1/Phase 2 study evaluating adoption and demonstration of adapted HIV and sexually transmitted infection prevention technique…
-
CLINICAL_TRIALS research · 2012-04-13Clinical Trial Update: Affect Management Intervention for Early Adolescents Wtih Mental Health Problems [Phase 1]
Phase 1 clinical trial update on an affect management intervention for early adolescents with mental health problems in individuals with HIV…
-
CLINICAL_TRIALS trial_result · 2012-04-12Clinical Trial Update: PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen [Phase 4]
Phase 4 trial evaluating switching from an efavirenz-containing regimen to maraviroc in patients who were initially virologically suppressed…
-
CLINICAL_TRIALS trial_result · 2012-04-12Clinical Trial Update: Raltegravir and Atazanavir Dosing Strategy Study [Phase 3]
Phase 3 clinical trial evaluating a dosing strategy for raltegravir with atazanavir in HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-12Clinical Trial Update: A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055) [Phase 3]
Phase 3 trial of raltegravir in a diverse cohort of HIV-infected patients has completed, with results posted on 2012-04-12.
-
CLINICAL_TRIALS research · 2012-04-12Clinical Trial Update: HIV Indicator Diseases Survey Across Europe - UK Arm
Clinical trial update on HIV indicator diseases survey in Europe focusing on the UK arm; the trial status is currently unknown.